Rule 17, Drugs (Prices Control) Order, 2013: Amendment of the list of scheduled formulation
Drugs (Prices Control) Order, 2013 - Rule 17
Text of rule 17
Amendment of the list of scheduled formulation
17. Amendment of the list of scheduled formulation.– (1) A
decision to amend the first schedule, clearly stating the reasons
thereof, shall be taken by the Government within sixty days of
receipt of communication from the Ministry of Health and Family
Welfare and the amendment(s) or revision, if required, in the first
schedule shall be notified and thereafter, the ceiling price(s) for the
medicine(s) added in the first schedule shall be fixed as per the
provisions of this order within a period of sixty days from the date of
the notification.
(2) The medicines omitted from the first schedule shall fall under the
category of non-scheduled formulations.
preceding calendar year on or before ist April of every year and
notify the same on the 1st day of April every year.
(2) The manufacturers may increase the maximum retail price (MRP)
of scheduled formulations once in a year, in the month of April, on
the basis of the wholesale price index with respect to previous
calendar year and no prior approval of the Government in this regard
Shall be required.
(3) Information about the revision, if carried out, shall be forwarded
to the Government in either electronic or physical form in Form-II
within a period of fifteen days of such revision and non-submission
of information under this sub-paragraph shall be construed as non
revision of maximum retail price (MRP) and the concerned
manufacturer shall be liable to deposit the amount charged over and
above the pre-revised maximum retail price (MRP), alongwith
interest thereon from the date of overcharging.
(4) In case of decline in wholesale price index, there shall be a
corresponding reduction in the maximum retail price and in case of
scheduled formulations produced or available in the market before
the date of notification of revised ceiling price, the manufacturers
shall ensure within a period of forty-five days of the date of such
notification that the maximum retail price (MRP) of such scheduled
formulation does not exceed the revised ceiling price (plus local
taxes as applicable) and information about the revision shall be sent
to the Government in either electronic or physical form in Form-II
within a period of fifteen days of such revision.
(5) Non-submission of information under the sub-paragraph (4) shall
be construed as non reduction in maximum retail price (MRP) and
the concerned manufacturer shall be liable to deposit the amount
charged over and above the maximum retail price revised based on
decline in wholesale price index, alongwith interest thereon as
overcharged amount from the date of overcharging.
17. Amendment of the list of scheduled formulation.— (1) A
decision to amend the first schedule, clearly stating the reasons
thereof, shall be taken by the Government within sixty days of
receipt of communication from the Ministry of Health and Family
Welfare and the amendment(s) or revision, if required, in the first
schedule shall be notified and thereafter, the ceiling price(s) for the
medicine(s) added in the first schedule shall be fixed as per the
provisions of this order within a period of sixty days from the date of
the notification.
(2) The medicines omitted from the first schedule shall fall under the
category of non-scheduled formulations.
Previous and next
Questions people ask
Is rule 17 of Drugs (Prices Control) Order, 2013 still in force?
No repeal of Drugs (Prices Control) Order, 2013 is recorded.